Trial intelligence / Profile preview

Orenitram for critical limb ischemia intervention

NCT00651885Phase 2Completed

Sponsor
Ochsner Clinic Foundation
Start
Mar 2008
Primary completion
Dec 2010
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of treprostinil in critical limb ischemia (CLI), sponsored by Ochsner Clinic Foundation. Started Mar 2008; status: completed.

02

Drugs

treprostinil
03

Conditions

critical limb ischemia (CLI)

Beyond the preview

Go deeper on NCT00651885.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00651885.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call